- Home
- KORE vs RVPH Comparison
KORE vs RVPH Comparison
Compare KORE & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KORE
- RVPH
- Stock Information
- Founded
- KORE 2003
- RVPH 2006
- Country
- KORE United States
- RVPH United States
- Employees
- KORE N/A
- RVPH N/A
- Industry
- KORE Telecommunications Equipment
- RVPH Biotechnology: Pharmaceutical Preparations
- Sector
- KORE Consumer Discretionary
- RVPH Health Care
- Exchange
- KORE Nasdaq
- RVPH Nasdaq
- Market Cap
- KORE 39.3M
- RVPH 32.8M
- IPO Year
- KORE N/A
- RVPH N/A
- Fundamental
- Price
- KORE $2.36
- RVPH $0.37
- Analyst Decision
- KORE Hold
- RVPH Strong Buy
- Analyst Count
- KORE 2
- RVPH 5
- Target Price
- KORE $2.75
- RVPH $9.00
- AVG Volume (30 Days)
- KORE 14.4K
- RVPH 2.4M
- Earning Date
- KORE 08-14-2025
- RVPH 08-13-2025
- Dividend Yield
- KORE N/A
- RVPH N/A
- EPS Growth
- KORE N/A
- RVPH N/A
- EPS
- KORE N/A
- RVPH N/A
- Revenue
- KORE $282,254,000.00
- RVPH N/A
- Revenue This Year
- KORE $4.66
- RVPH N/A
- Revenue Next Year
- KORE $6.71
- RVPH N/A
- P/E Ratio
- KORE N/A
- RVPH N/A
- Revenue Growth
- KORE N/A
- RVPH N/A
- 52 Week Low
- KORE $1.10
- RVPH $0.30
- 52 Week High
- KORE $4.88
- RVPH $4.28
- Technical
- Relative Strength Index (RSI)
- KORE 47.32
- RVPH 29.52
- Support Level
- KORE $2.20
- RVPH $0.30
- Resistance Level
- KORE $2.48
- RVPH $0.83
- Average True Range (ATR)
- KORE 0.19
- RVPH 0.07
- MACD
- KORE -0.01
- RVPH -0.04
- Stochastic Oscillator
- KORE 51.61
- RVPH 11.25
About KORE KORE Group Holdings Inc.
Kore Group Holdings Inc provides Internet of Things (IoT) solutions and services. In addition to providing critical services to customers globally, it enables them to manage, deploy, and scale their IoT applications and use cases. It offers connectivity services, location-based services, device solutions, and managed and professional services for the development and support of IoT technology for the Machine-to-Machine market. It derives revenue from IoT Connectivity services, IoT Solutions services, SIMs (IoT Connectivity), and IoT devices (IoT Solutions). Geographically, the company generates the majority of its revenue from the United States and the rest from other countries.
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.